Synthesis of Possible Cancer Chemotherapeutic Compounds Based on Enzyme Approach. V. Tetrazolium Nitrogen Mustards1

Universal Verification Platform and Star Simulator for Fast Star Tracker Design

Developing star trackers quickly is non-trivial. Achieving reproducible results and comparing different algorithms are also open problems. In this sense, this work proposes the use of synthetic star images (a simulated sky), allied with the standardized structure of the Universal Verification Methodology as the base of a design approach. The aim is to organize the project, speed up the development time by providing a standard verification methodology. Future rework is reduced through two methods: a verification platform that us shared under a free software licence; and the layout of Universal Verification Methodology enforces reusability of code through an object-oriented approach. We propose a black-box structure for the verification platform with standard interfaces, and provide examples showing how this approach can be applied to the development of a star tracker for small satellites, targeting a system-on-a-chip design. The same test benches were applied to both early conceptual software-only implementations, and later optimized software-hardware hybrid systems, in a hardware-in-the-loop configuration. This test bench reuse strategy was interesting also to show the regression test capability of the developed platform. Furthermore, the simulator was used to inject specific noise, in order to evaluate the system under some real-world conditions.

Synthesis and analgesic evaluation of some 5-[β-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-tetrazoles

A series of novel 5[beta-(phenothiazinyl-10-yl)ethyl]-1-(acyl)-1,2,3,4-tetrazoles (3-14) have been synthesized via condensation of 5-[beta-(phenothiazinyl-10-yl)ethyl]-1-2,3,4-tetrazole (2) with various acylating/sulphonating reagents. 5-[beta-(phenothiazinyl-10-yl)ethyl]-1-2,3,4-tetrazole was synthesized by cyanoethylation of phenothiazine with acrylonitrile and Triton B, followed by the cycloaddition of 3-(phenothiazin-10-yl)-propionitrile (1) with sodium azide and ammonium chloride. The compounds were screened for analgesic activity, anti-inflammatory activity and ulcerogenicity index. Out of the 12 compounds synthesized, compound (5) 5[beta-(phenothiazinyl-10-yl)ethyl]-1-(benzoyl)-1,2,3,4-tetrazole, compound (11) 5[beta-(phenothiazinyl-10-yl)ethyl]-1-(p-tolyl)-1,2,3,4-tetrazole showed promising analgesic activity and compound (6) 5[beta-(phenothiazinyl-10-yl)ethyl]-1-(p-chlorobenzoyl)-1,2,3,4-tetrazole and compound (8) 5[beta-(phenothiazinyl-10-yl)ethyl]-1-(p-nitrobenzoyl)-1,2,3,4-tetrazole showed promising anti-inflammatory activity.